Mission & Vision

Core Values

EXCELLENCE

COMPASSION

INTEGRITY

Since its founding in 2007, OncoCare Cancer Centre in Singapore has been committed to providing our patients the best available cancer care through expert, personalized treatments, driven by state-of-the-art knowledge and making a difference through efficient delivery, effective communication, and compassionate touch.

We seek to cure, relieve, and partner with our patients on their cancer journey by using our understanding of the detection, diagnosis, treatment, and prevention of cancer. We aim to reduce toxicity, control symptoms, prevent disfigurement, and eliminate pain, and emotional distress associated with cancer-directed therapy.

We believe that today’s research leads to tomorrow’s cure and our doctors are actively involved in clinical research and trials, and have a dynamic collaboration with regional cancer institutions and laboratories. We have access to the latest commercial imaging, and molecular genetic laboratories associated with world-class science and technology.

VISION

To become a leading centre in cancer care in the region

MISSION

Adding years and quality of life to all patients through efficient, knowledge-based, integrated cancer practice and personalised treatments

VALUES

Excellence: Excel in service by being in the forefront of cancer research & precision investigations, thereby providing beyond best evidence-based cancer care.

Compassion: Give our best every day to serve, to care and to heal patients with sincerity and honesty.

Integrity: Act honestly, adhere our practice consistently in accordance to medical professionalism, social standards, and moral values of society.

OncoCare's Story

Follow OncoCare’s inspiring journey of growth and expansion.

Our journey is marked by significant milestones, from opening new centres to receiving industry regconition, all driven by our commitment to improving patient outcomes and patient support. 

In 2007, Dr Tay Miah Hiang and Dr Peter Ang founded OncoCare Cancer Centre at Gleneagles Medical Centre, marking the beginning of a dedicated service to cancer patients in Singapore.

In 2008, OncoCare opened an additional centre at Gleneagles Medical Centre, expanding our capacity to serve patients.

By 2011, OncoCare had grown further, opening a new centre at Mount Elizabeth Orchard Medical Centre.

OncoCare continued its growth trajectory in 2012 by opening another centre at Mount Elizabeth Novena Medical Centre.

In 2014, we consolidated two centres at Gleneagles Medical Centre, moving into a larger unit to better serve our patients. We also relocated our clinic at Mount Elizabeth Orchard to a bigger, more advanced facility.

In 2015, OncoCare established the “OncoCare Medical Bursary” for needy students at the National University of Singapore Yong Loo Lin School of Medicine. We relocated our clinic at Mount Elizabeth Novena Medical Centre to a larger unit and expanded further by opening another centre at Mount Alvernia Hospital.

In 2017, OncoCare opened another centre at Gleneagles Medical Centre and launched the first women’s cancer clinic in Singapore, “OncoCare Women’s Cancer Clinic,” at Mount Elizabeth Novena Medical Centre.

OncoCare Cancer Centre also sponsored the Singapore Junior Squash Open tournament.

OncoCare was honoured to be awarded the 2018 Enterprise 50 Award, only for the top 50 SMEs in Singapore. Our centre was recognized for its exceptional service and contributions to the medical field.

In 2019, we opened another centre at Mount Elizabeth Orchard and became the first independent private cancer centre to be awarded the Singapore Quality Class with Service.

In 2020, OncoCare launched the “Bright Future Move 2020” initiative, donating $100,000 to the Straits Times School Pocket Money Fund. This initiative underscores our commitment to giving back to the community.

OncoCare’s commitment to excellence was recognised with several awards in 2022, including the Philanthropy Award for Children’s Cancer Foundation of Singapore, the GlobalHealth Asia-Pacific Award, and the Expat Living Readers’ Choice Awards for the Best Cancer Specialist in Singapore.

  • Raised funds for the Singapore Cancer Society to support cancer research and awareness during the Cycle for Hope Event 2023.
  • Awarded the GlobalHealth Asia-Pacific Award 2023
  • Awarded the Expat Living Readers’ Choice Awards 2023 for the Best Cancer Specialist in Singapore

Raised funds for the Singapore Cancer Society to support cancer research and awareness during the Cycle for Hope Event 2024.

OncoCare Medical Malaysia Sdn Bhd and Thomson Hospital Kota Damansara have launched an exciting new partnership, joining forces to bring together leading oncologists and supportive care specialists under one state-of-the-art cancer care facility.

May be an image of 4 people and text

Read more here.

OncoCare’s Expansion of Specialists

OncoCare’s story is more than a timeline of events; it reflects our dedication to providing top-quality cancer treatment.

We have grown into a centre that offers multi-disciplinary care for various types of cancers.

We continually add specialists to our team to ensure our patients receive comprehensive, personalised treatment, striving to deliver holistic and effective cancer care.

In 2007, Dr. Tay Miah Hiang and Dr. Peter Ang founded OncoCare Cancer Centre at Gleneagles Medical Centre, each bringing their own subspecialty expertise.

  • Dr Tay Miah Hiang specialises in Urological Cancers (Prostate, Kidney, Testicular, Bladder, Liver), Brain Tumour, Lung Cancer, Stomach Cancers (Colon, Rectum).
  • Dr Peter Ang specialises in Breast Cancer, Breast Cancer Genetics, Young-onset Breast Cancer and Lung Cancer.

New Senior Medical Oncologist Acquisition: Dr Leong Swan Swan.

Dr Leong specialises in Thyroid Cancer, Head & Neck Cancer (including NPC and oral cancers), Lung Cancer, Malignant Pleural Mesothelioma, Thymomas, and Thymic Carcinomas.

New Senior Medical Oncologist Acquisition: Dr Wong Nan Soon.

Dr Wong specialises in Breast Cancer, Gastrointestinal Cancers, and Neuroendocrine Cancers.

 

New Senior Medical Oncologist Acquisition: Dr Benjamin Chuah.

Dr Ben specialises in Gastrointestinal Cancers (Oesophageal, Gastric, Biliary Tract, Pancreatic), Liver Cancer (Hepatocellular Carcinoma), Neuroendocrine Cancers, and Colorectal Cancers.

New Senior Medical Oncologist Acquisition: Dr Kevin Tay.

Dr Kevin specialises in Women-related Cancers (Breast & Gynaecological Cancers), Blood cancers (Lymphoma, Myeloma & Leukemia), Soft Tissue & Bone Sarcomas, Rarer Cancers (Brain, Melanoma / Skin Cancers), and HIV-related Cancers

New Senior Medical Oncologist Acquisition: Dr Thomas Soh.

Dr Thomas specialises in Gastrointestinal cancers (Colon, Rectal, Stomach, Esophagus), Hepatobiliary Cancers (Liver, Pancreas, Cholangiocarcinoma, Gallbladder), Neuroendocrine Cancers, GIST.

New Senior Medical Oncologists Acquisition: Dr Tan Sing Huang & Dr Akhil Chopra

  • Dr Tan Yew Seng specialises in Palliative Care and end-of-life care for patients with cancer or non-cancer terminal illnesses.
  • Dr Tan Sing Huang specialises in Breast Cancers, Gynecological Cancers, Lung Cancers, and Gastrointestinal Cancers (Colon, Rectum, Pancreas, Liver, Gastric).
  • Dr Akhil Chopra specialises specialises in Lung Cancer, Genitourinary Cancers (Prostate Cancer, Kidney Cancer, and Bladder Cancer), Lymphomas, and Head & Neck Cancer including Nasopharyngeal Cancer.

New Senior Medical Oncologists Acquisition: Dr Tan Chee Seng & Dr Lim Sheow Lei

  • Dr Tan Chee Seng specialises in Lung Cancer (Small Cell & Non-small Cell), Thymomas & Thymic Carcinomas, Malignant Pleural Mesothelioma, Thyroid Cancer, Head & Neck Cancers (E.g. Tongue, Nose / Nasopharyngeal Cancer (NPC), Tonsil, Throat Cancers) General Oncology (Gastrointestinal, Occult Primary).
  • Dr Lim Sheow Lei specialises in Gynecological Cancers (Cervical, Endometrial / Ovarian, Uterine Neoplasms, Vulvar, Gestational Trophoblastic Neoplasia, Primary Peritoneal Cancers).

New Senior Medical Oncologist Acquisition: Dr Angela Pang.

Dr Angela specialises in Gastrointestinal Cancers, Bone / Soft Tissue Sarcomas, Breast Cancer and Older Adults with Cancers.